Recent Updates
Recently added Catalysts
VNRX Positive Sentiment

Immunoprecipitation of tumor associated ctDNA fragments for novel lung cancer liquid biopsy

Friday, March 22, 2024 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: The poster titled 'Immunoprecipitation of tumor associated ctDNA fragments for novel lung cancer liquid biopsy' was presented at the ELCC 2024 conference. This research focuses on utilizing ctDNA fragments for developing a liquid biopsy method aimed at enhancing lung cancer diagnostics. The findings may contribute to better prognostic tools in oncology.
Price reaction · baseline $14.6 (2024-03-21 close) · hit pre-market · 5 other VNRX headline(s) in the window, move may be shared
day 0 close
+0.4%

Market Sentiment Analysis

POSITIVE FACTORS

  • Presentation at a prominent conference (ELCC 2024)
  • Focus on innovative liquid biopsy techniques for lung cancer
  • Potential for improved cancer diagnostics with ctDNA analysis

Full Press Release Details

Poster titled: Immunoprecipitation of tumor associated ctDNA fragments for novel lung cancer liquid biopsy
Presented at: ELCC 2024
Pamart et al

Related Articles

• Press Releases Data Showing the Prognostic Value of its Nu.Q® Cancer Test
• Poster & Publications Cytokine-induced chromatin accessibility in whole blood neutrophils links to sepsis transcriptional states

Data Showing the Prognostic Value of its Nu.Q® Cancer Test

Cytokine-induced chromatin accessibility in whole blood neutrophils links to sepsis transcriptional states

• Share
• Tweet
• Share on Facebook
• Share

Subscribe for Volition product updates .

Or, click here for Investor Updates and press releases .

" * " indicates required fields

Frequently Asked Questions

What was presented at ELCC 2024?

A poster on immunoprecipitation of tumor associated ctDNA fragments for lung cancer.

What is the focus of the ctDNA research?

The research aims to develop a novel liquid biopsy method for lung cancer diagnostics.

Who are the authors of the poster?

The poster was authored by Pamart et al.

What is ctDNA?

ctDNA refers to circulating tumor DNA, which can provide insights into cancer diagnostics.

ShareAdd on Google
Tags: VNRX Viatris Investor Conferences Healthcare ctDNA liquid biopsy lung cancer ELCC 2024
Last updated: Mar 22, 2024

Biotech snapshot

Cash runway
$3M liquidity · $2M/mo burn
~1 mo
High dilution risk